1. Ma, H., Y. Liu, X. Mai, Y. Liao and K. Zhang et al., 2016. Identification of the constituents and metabolites in rat plasma after oral administration of HuanglianShangqing pills by ultra high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal., 125: 194-204.
   CrossRef  |  Direct Link  |  
2. Liu, J., K. Zhang, X. Mai, J. Wei and Y. Liao et al., 2016. Synthesis, anticancer evaluation and docking study of 3-benzyloxyhydantoin derivatives. Med. Chem., 12: 37-47.
   CrossRef  |  Direct Link  |  
3. Xu, D., C. Liu, X. Mai and Y.J. Liao, 2014. Detection of the related substances of methicillin sodium by RP-HPLC. Asian J. Chem., 26: 8651-8652.
4. Ren, F., Y. Zhong, X. Mai, Y.J. Liao and C. Liu et al., 2014. Synthesis and anticancer evaluation of benzyloxyurea derivatives. Chem. Pharmaceut. Bull., 62: 898-905.
   CrossRef  |  Direct Link  |  
5. Xia, H.Y., X. Mai, B. Mai, W.J. Zhong, C. Liu, Y.J. Liao and L.H. Feng, 2013. Synthesis, crystal structure and in vitro antitumor activity of benzyloxyurea and benzyloxyhydantoin derivatives. Asian J. Chem., 25: 10043-10049.
6. Liao, Y., X. Liu, C. Liu, G. Zhou and W. Wang et al., 2013. Determination on the dissolution rate of doxepin hydrochloride tablets produced by different manufacturers in China with fiber-optic medicine dissolution/release rate process test system. Asian J. Chem., 25: 8587-8592.
7. Liu, C., X. Mai, C. Wang and C.P. Wang, 2012. Impurity profiles of rifaximin produced in China. Die Pharmazie: Int. J. Pharmaceut. Sci., 67: 283-287.
   CrossRef  |  Direct Link  |  
8. Liu, C., X. Mai, C. Wang and C. Wan, 2012. Structural elucation of a novel impurity in rifaximin. Die Pharmazie: Int. J. Pharmaceut. Sci., 67: 423-425.
   CrossRef  |  Direct Link  |  
9. Liu, C., X. Mai and C. Wang, 2012. Physical characteristics of the I type and II type crystal of rifampicin. Asian J. Chem., 24: 2793-2795.